|
|
|
Types of Cancer
There are many different types of
cancer. Several factors, including location and how the cancerous
cells appear under the microscope, determine how cancer is
diagnosed. For example, there are several forms of breast cancer,
classified according to where the tumors originate within the
breast, and their tendency to invade surrounding organs and tissue.
All cancers, however, fall into one of four broad categories:
Carcinomas
are tumors that arise in the tissues that line
the body's organs. About 80% of all cancer cases are carcinomas.
Sarcomas
are
tumors that originate in bone, muscle,
cartilage, fibrous tissue or fat.
Leukemias
are cancers of the blood or blood-forming
organs.
Lymphomas
affect
the
lymphatic system, a network of vessels and nodes that acts as the
body's filter. The lymphatic system distributes nutrients to blood
and tissue, and prevents bacteria and other foreign "invaders" from
entering the bloodstream. There are over 20 types of lymphoma. |
|
|
Blue Box 1
Scan Below
|
Treatment of
Cancer
There are four
major types of cancer treatment: surgery, radiation therapy,
chemotherapy, and immunotherapy. These therapies can be used either
alone or in combination with each other. Location, size and stage of the
tumor, as well as your overall health, determines which treatment or
treatments you will receive. Many new treatments, including cancer
vaccines and gene therapy, are being studied in clinical trials.
Patients at M. D. Anderson
are treated by a team of specialists tailored to meet a patient's
individual needs. The team may include a medical oncologist, a surgeon,
a radiation oncologist, a pathologist, and other health care
professionals. This multidisciplinary approach to cancer care was
pioneered by M. D. Anderson.
Current methods of cancer treatment:
-
Surgery is the oldest
form of cancer treatment. About 60% of cancer patients will undergo
some sort of surgery, either by itself or in combination with other
therapies.
-
Chemotherapy uses
powerful drugs to kill cancer cells, control their growth, or to
relieve pain symptoms.
-
Radiation uses large doses of high-energy
beams or particles to destroy cancer cells in a specifically targeted
area.
-
Immunotherapy, also
known as biologic therapy, stimulates the body's own defense systems
to fight cancer.
-
Gene Therapy identifies missing or defective
genes that cause cancer or increase cancer risk, and replaces them
with normal copies.
-
Clinical Trials, in which new treatment
methods are tested on human subjects, can provide options for patients
whose cancer has not responded to standard therapies.
|
|
Prevention of Cancer
Up to 85% of cancers can
be prevented by avoiding environmental risk factors like smoking, sun exposure,
alcohol abuse and poor nutrition. Of course, things like age, race, gender and
family history cannot be changed, but knowing your personal cancer risk can help
you devise a prevention strategy with regular screenings and healthy lifestyle
choices. Having one or more risk factors for cancer doesn't mean you will get
cancer. In fact, many people considered high-risk never develop cancer while
others with no known risk factors become ill. |
Just the Facts…Smoking & Tobacco Use
(pdf)
Tobacco use, particularly
cigarette smoking, is the single most preventable cause of death in the
United States. The number of deaths per year from smoking exceeds the number
of deaths per year from all accidents, suicides, drug use, homicides and
AIDS combined. An estimated 45 million U.S. adults are smokers, and more
than a third of all U.S. high school students smoke cigarettes.
The good news is that
no matter how old you are, it’s never too late to improve your health by
kicking the tobacco habit for good
|
|
Want to Quit? Treatment at M. D.
Anderson |
Smoking Cessation Programs for
Patients and the Public
It's never too late to improve your health by kicking the tobacco
habit. One of our studies may help. Call (713) 792-2265 for more
information.
|
|
|
Misspelled words used to find this page 2 of 3.carcinoma,
carsinoma, calsinoma, carkinoma, carcinoa, carcnoma, carcinma, carcioma,
carinoma, cacinoma, crcinoma, calcinoma, carc1noma, carc1moma, carcinooam,
carcinomoa, carcinooma, carcionoma, carcniooma, caricnooma, cacrinooma,
cracinooma, acrcinooma, smoking, soking, smking, smoing, smokng, smokig,
smalking, smalkint, smokint, smokiegnt, smokeyng, csimalkiegng, csimokeynt,
scimokeigng, smalkiegng, smokeynt, csimalking, scimokeignt, smalkiegnt,
smalkeyng, csimalkint, scimalkeigng, scimoking, smalkeynt, csimalkeyng,
scimokiegng, scimokint, smokeigng, csimokeigng, scimokiegnt, scimokeyng,
smokeignt, csimokeignt, scimalkiegng, scimokeynt, smalkeigng, csimalkeigng,
csimoking, scimalking, smalkeignt, csimokiegng, csimokint, scimalkint,
smokiegng, csimokiegnt, csimokeyng, scimalkeyng, snok1mg, snokimg, smokimg,
smokign, smoknig, smoikng, smkoing, somking, msoking, smokin, moking,
heledytery, heretitarie, hearditalie, hereditary, heredetarie, healdetary,
hearditerie, heardytarie, herditary, hereditury, heretitalie, heretitary,
heardetarie, heledetary, helediterie, hereditalie, hereitary, heredytury,
heretiterie, heretitaly, heredetalie, heledetaly, herediturie, heredytalie,
heredtary, hearditury, heretiturie, hereditery, heretitery, heledetarie,
heredetery, heredyturie, healditarie, herediary, heardytury, heletitarie,
heredytery, heretitury, heredeterie, heardetery, hearditurie, heleditarie,
hereditry, healditury, hearditery, heletitary, heredeturie, heledetery,
helediturie, heledytarie, hereditay, heleditury, heardytery, heletitaly,
hearditaly, heredetury, heredetary, heleditalie, hereditarie, heledytury,
healditery, heletitery, heardytaly, heardetury, heardetary, herediterie,
heredytarie, hreditary, heleditery, heletitury, heardetaly, heledetury,
heredetaly, heredyterie, hearditarie, heeditary, heledytary, heleditaly,
heredytary, heledytaly, hearditary, heardytary, hereditaly, heredytaly,
healditary, healdytary, heleditary, hered1tary, hereditayr, hereditray,
herediatry, heredtiary, hereidtary, herdeitary, heerditary, hreeditary,
ehreditary, hereditar, ereditary, sarcoma, srcoma, sacoma, saroma, sarcma,
sarcoa, sarkoma, salcoma, salcomas, sarcomas, srcomas, sacomas, saromas,
sarcmas, sarcoas, sarcoms, sarkomas, sarconas, sarcomsa, sarcoams, sarcmoas,
sarocmas, sacromas, sracomas, asrcomas, arcomas, leukemia, leukmia, leukeia,
leukema, lukemia, lekemia, leuemia, leukemea, reukemea, elukemea, leukemai,
elukemia, elukemai, reukemia, reukemai, elukemais, reukemias, reukemais,
lukemias, lekemias, leuemias, leukmias, leukemias, leukeias, leukemais,
leukemas, elukemias, leukemis, 1euken1as, leuken1as, leukenias, leukemisa,
leukeimas, leukmeias, leuekmias, lekuemias, luekemias, eukemias, lymphoma,
lyphoma, lymhoma, lympoma, lymphma, lymphoa, lmphoma, lymfoma, limphoma,
limfoma, rymphoma, rymfoma, rimphoma, rimfoma, 1ynphomas, lynphomas,
lymphomsa, lymphoams, lymphmoas, lympohmas, lymhpomas, lypmhomas, lmyphomas,
ylmphomas, lymphoms, lymphoas, lymphmas, lympomas, lymhomas, lyphomas,
lmphomas, ymphomas, lymphomas, symptom, symppedom, symppedum, simppedom,
smptom, simppedum, syptom, symtom, sympom, symptm, symptum, simptum, simptom,
simptoms, symptoms, sympoms, symptms, symptos, symppedoms, simppedoms,
smptoms, syptoms, symtoms, synptoms, symptosm, symptmos, sympotms, symtpoms,
sypmtoms, smyptoms, ysmptoms, ymptoms, biopsy, byopcie, biopsie, byopsie,
biopcy, byopcy, biopcie, byopsy, biopsi, byopsi, b1opsy, biopys, biospy,
biposy, boipsy, ibopsy, biops, biopy, biosy, bipsy, bopsy, iopsy, blood,
brood, bloud, broud, b1od, blodo, bolod, lbood, blod, treatment, treatent,
treatmnt, treatmet, teatment, treament, tleetmiegnt, tratmiegnt,
trheatmeignt, tleaitmant, tleaitmiegnt, tretmiegnt, trheaitmeignt,
tlheatment, tlheatmiegnt, treetmiegnt, tleatmeignt, tlheatmant, treaitment,
treaitmiegnt, tlatmeignt, tlheaitment, treaitmant, trheatmiegnt, tletmeignt,
treatmeignt, trheatment, trheaitmiegnt, tleetmeignt, tratmeignt, trheatmant,
tleatmiegnt, tleaitmeignt, tretmeignt, trheaitment,
|
| |
What are Clinical Trials? - Clinical
trials are cancer research studies. Learn the basics and how they're
conducted.
|
|
| |
Clinical trials are cancer research studies that involve
people. The main purpose of a clinical trial is to find a
better way to prevent,
diagnose
or treat a disease. Clinical trials are part of a long,
careful research process. Patients who participate in a
clinical trial receive drugs or procedures that already have
been researched in successful laboratory and/or animal
studies. Most clinical trials study new drugs or procedures,
but some study drugs or procedures that have already
received approval by the U.S. Food and Drug Administration.
All patients who participate in
clinical trials are volunteers. They
can choose to stop their participation in a clinical trial
at any time.
Why are clinical trials important?
Clinical trials are important to develop
new treatments for cancer. Many of today’s standard cancer
treatments are based on the results of previous clinical
trials.
Who are the members of the
clinical trials team?
Principal Investigator: The
principal investigator, usually a doctor, is responsible
for the design, development and conduct of the clinical
trial. He or she evaluates data and helps participating
doctors manage the trial. You will continue to see your
primary doctor if he or she is not the principal
investigator.
Research Nurse: The
research nurse directs and coordinates patient care during
a clinical trial, and is a good contact for patients who
have questions. He or she will:
- Teach you about participation
in the clinical trial
Make sure the protocol’s
instructions are followed
Teach you about side effects
Help manage clinical trial
data
Clinic Nurse: The
clinic nurse coordinates general patient care regardless
of whether you participate in a clinical trial. He or she
will meet with you during your doctor visits. Because the
clinic nurse is a part of your health care team, you also
may ask him or her questions.
What are the types of
clinical trials?
Therapeutic trials
test new drugs, surgery techniques, radiation therapy
procedures or other treatment methods on people with
specific types and stages of cancer.
Prevention trials study
how healthy people may prevent cancer. People at high risk
of getting cancer may benefit from participation in a
prevention trial.
Early-detection/screening trials
discover ways to find early-stage cancer.
Diagnostic trials find new and
better ways to determine if someone has cancer – and, if
so, where the cancer is located in the body; how much
cancer is there; and whether or not it has spread to other
parts of the body.
Quality of life/supportive care trials
seek to improve the comfort and quality of life of
patients and their families or caregivers.
|
|
What are the Phases of Clinical Trials? - Information
on how new treatments progress from the laboratory to clinical
usage.
|
|
|
After promising treatments are
explored in animal and/or laboratory studies, researchers
perform clinical trials. Once the drug, device or procedure
enters the clinical trials process, it must go through
several phases:
- Phase I trials determine the
safety of a new treatment
- Phase II trials determine whether
a certain kind of cancer responds to a new treatment
- Phase III trials study whether a
new treatment is better than standard treatment
- Phase IV trials find more
information about a new treatment that has been already
approved for use in patients

Phase I Trials – Determine safety
The goal of a Phase I trial is to find the safest dose of a
new drug that patients can receive without creating harmful
side effects. During a Phase I trial, the researcher also
examines the best way to give a new drug, such as by mouth
or intravenously (through a vein).
Throughout Phase I trials,
researchers monitor whether the new drug shows any effect
against cancer. However, because these trials often are
testing drugs for the first time in people, the goal is to
find out how to give the drug in a safe way, and not how
well it fights cancer.
Phase I trials usually include 15
to 30 people. Usually patients who have undergone standard
treatments without success and have no other options are
eligible to participate in a Phase I trial.
Typically, patients in Phase I
trials are divided into cohorts – small groups of patients –
usually around three people. The first cohort receives a low
dose of the new drug. Researchers may collect blood or urine
samples to measure drug levels. If no severe side effects
occur, then a new cohort receives a higher dose of the same
drug. The dose increases with each new cohort until the
researchers see too many side effects or until they
determine the best dose.
If the treatment successfully
passes through a Phase I trial, then it will move forward to
be studied in a Phase II trial.
Phase II Trials – Determine
whether the new treatment works
The main goal of a Phase II trial is to examine how well the
new treatment works to fight a certain kind of cancer. Less
than 100 patients usually participate in a Phase II trial.
Patients who volunteer for a Phase II trial may have been
treated with chemotherapy, biotherapy, surgery or radiation
and still need further treatment.
In addition to evaluating how well
the treatment works against the cancer, doctors continue to
monitor side effects. Since more patients participate in
Phase II studies, some of them may experience side effects
that patients in the Phase I clinical trial did not have.
If the new treatment seems to be
effective against cancer in a certain percentage of
patients, researchers may consider it successful enough to
continue study in a Phase III clinical trial.
Phase III Trials – Study
whether the new treatment is better than standard treatment
The goal of a Phase III trial is to compare the new
treatment with the standard treatment. Researchers track
whether a new treatment is better than, the same as, or less
effective than the standard treatment.
Phase III trials may include
hundreds to thousands of patients around the country or
world. In general, each patient enrolled in a Phase III
clinical trial has an equal chance of participating in one
of two or more arms (groups) of the
study. In a clinical trial with two arms:
- The control group receives
the standard treatment
- The investigational or experimental
group receives the new treatment being tested
Randomization
is the process of assigning participants to
groups. Randomization helps avoid bias in the clinical
trial. Bias occurs when human choices or other factors not
related to the treatment being tested change a study’s
results.
Neither the patient nor
the doctor can choose whether the patient is in the control
group or the experimental group. Regardless of which group a
patient is assigned to, either he or she will receive the
best standard treatment available or the new treatment that
researchers believe is as good as, or better than, the
standard treatment.
Single Blind Versus
Double Blind Trials
- Single blind studies: patients do
not know whether they are in the experimental or control
group
- Double blind studies: neither the
patients nor the researchers know which patients are in
each group (although this information is recorded and on
file if needed)
FDA Approval
The role of the U.S. Food and Drug Administration (FDA) is
to make sure medical treatments are safe and effective for
people to use. Researchers submit their clinical trial
results to the FDA, and based on the information, the FDA
may approve the drug or treatment. Then it becomes available
to all patients and sometimes becomes the new standard
treatment.
Phase IV Trials – Find more information about
the new treatment
Phase IV clinical trials are not as
common as Phase I, Phase II and Phase III trials. In Phase
IV trials, researchers study drugs and/or treatments that
have already received FDA approval. The goal of Phase IV
trials is to study how safe and effective a drug or
procedure is over time. |
|
Information about enrolling in
clinical studies and informed consent.
Participating in Clinical Trials
How
does M. D. Anderson protect patients?
When conducting clinical trials, M. D. Anderson’s most
important responsibility is to protect patients through
well-designed protocols,
a dedicated Institutional Review Board (IRB) and a careful informed
consent process.
Clinical Trial Protocol
A protocol is a detailed
plan that explains what will be done in a clinical trial and why. It
outlines how many patients will participate, what medical tests they
will receive and how often, and the treatment and monitoring plan.
Researchers must follow the protocol approved by M. D. Anderson’s
Institutional Review Board (IRB).
If you have questions or concerns about safety while
participating in a clinical trial, please contact a member of your
clinical trial team. If you still have questions about the study or
your rights as a participant, contact the Chairman of the
Institutional Review Board (IRB) at (713) 792-2933.
The Institutional Review Board
M. D. Anderson has four Institutional Review Boards (IRBs). An IRB
is a committee of people, such as doctors, nurses, scientists,
dentists, chaplains, social workers, attorneys and patients who are
responsible for protecting clinical trial participants and making
sure that the trials follow federal laws.
Before
a clinical trial can begin, the IRB reviews and approves the
protocol to make sure that it is based on reliable scientific
evidence. The IRB attempts to ensure that the protocol will not
cause excessive harm to any patient.
After a clinical trial begins, the IRB monitors the trial at
least once a year and stops it if any safety concerns arise. For
example, if a patient developed dangerous side effects, then the
trial would be stopped. It also may stop a clinical trial early if
it becomes clear that the new treatment is much more effective than
standard treatment, so that all participants may receive the better
treatment.
The FDA regulates M. D. Anderson’s IRBs by auditing IRB minutes,
staff and facilities every five years. FDA officials also can visit
M. D. Anderson at any time and review anything they choose related
to clinical trials.
The Informed Consent Process
If you have the option to participate in a clinical trial, you will
go through a process called
informed consent. You will learn details about a specific
clinical trial so that you may decide whether to participate. The
informed consent process protects patients by ensuring that they
understand the clinical trial’s plan before agreeing to participate.
The
researcher or nurse from the clinical trial team will review the
informed consent form in detail with you. This form explains a
specific clinical trial’s purpose, procedures, risks and benefits.
You will be encouraged to ask questions about terms or ideas that
are confusing. A family member or friend may be helpful by listening
to the explanation, asking questions and recording answers. Some
doctors encourage patients to bring tape recorders so they can
review the information afterwards.
You can take the informed consent form with you to think about
whether you would like to participate in the clinical trial.
Information on the Informed
Consent Form
Informed consent
forms are different, but they should include:
- The reason for the clinical trial (what the researchers hope
to learn)
- Who is eligible to take part in the clinical trial
- What is known about the type of treatment being studied
- The possible risks and benefits (based on what is known so
far)
- Other treatments that may be options
- The clinical trial’s design (randomized, single blind, double
blind, etc.)
- Types of tests, the number of tests and doctor’s visits
required
- Who is responsible for the costs of the clinical trial (tests,
doctor’s visits, etc.)
- Who is responsible for the costs if a patient needs additional
care as a result of the clinical trial
- A statement about conflicts of interest
- A statement about protecting the patient’s privacy
- A statement about the clinical trial being voluntary and the
patient’s rights to leave the clinical trial at any time
- Contact information for further questions
Signing the Form
If you want to participate in a clinical trial after learning all
that is involved and what you would be expected to do, then you, the
trial’s principal investigator (or nurse, if called for in the
protocol) and a witness will sign and date three copies of the
informed consent form. You will keep one copy, one will go in your
medical file, and another will go in the principal investigator’s
file.
The informed consent process does not end once you sign the form.
If new benefits, risks or side effects are found during a trial, the
doctor must inform all of the participants.You will be encouraged to
keep asking questions throughout the trial.
M. D. Anderson will take appropriate steps to keep your personal
information private. However, there is no guarantee of absolute
privacy. The Food and Drug Administration (FDA), the IRB of M. D.
Anderson and the clinical trial’s sponsor might review your record
to collect data or to see that the research is being done safely and
correctly. Under certain circumstances, the FDA could be required to
reveal the names of participants.
Clinical Trials at M. D. Anderson - a current
list of clinical trials that are recruiting patients.
|
Clinical Trials at M. D. Anderson Cancer Center
View studies by cancer type
Breast, prostate, colon cancer and others—use this site to
see what clinical trials are now in progress for specific
cancers.
View studies by treatment
Have you heard of a particular new treatment that is being
studied? See if M. D. Anderson is one of the clinical trial
sites for that treatment. Scroll down the list to "No
Treatment Agents Listed" or "None" to view cancer
prevention, diagnosis, control or other non-treatment
clinical trials.
View studies by study number
Staff at M. D. Anderson are most likely to be familiar with
the study numbers assigned to clinical trials. Look here if
you know the number of the clinical trial that interests
you.
View studies by physician
Have you heard of a certain M. D. Anderson doctor? Use this
link to see what clinical trials that doctor is conducting.
View studies by phase
Clinical trials are conducted in
phases from I to IV. Each phase tests specific aspects
of experimental therapies, such as dosage, toxicity and
effectiveness in comparison to standard treatments. More
participants are enrolled as the trials progress through
each phase. |
|
Frequently Asked Questions - Insurance
coverage, costs, resources and more.
| |
Frequently
Asked Questions About Clinical Trials
What should I consider before participating in a clinical trial?
Each clinical trial is
unique and has its own benefits and risks.
Some possible benefits of
participation:
- You may have more treatment options
- If the new drug or treatment works,
you may be among the first to benefit
- You may be able to help future
cancer patients
- The trial sponsor may pay for some
of your medical care or tests. (Ask your doctor or the
research nurse about who is responsible for these costs before
agreeing to participate.)
Some possible risks
include:
- Side effects may be worse than standard treatment
- Side effects may occur that the doctor does not expect
- New treatments do not always turn out to be better
than, or as good as, standard treatment
- The new treatment may not work for you even if it works
for other patients
- Your health insurance company may not pay for your
clinical trial care or tests. (Ask your doctor or the research
nurse about who is responsible for these costs before agreeing
to participate.)
- You may have to receive all of your tests and treatment
at M. D. Anderson. Depending on where you live, this may
require more time and money for travel.
What questions should I ask about participating
in a clinical trial?
As the patient, it is
your decision whether to participate in a clinical trial. Since
it is your choice, ask as many questions as you need until the
answers are clearly understandable to you. For some examples,
download our
Questions to Ask About Clinical Trials
document (pdf) to help get the information you need to make an
informed decision.
How
will I know if I am eligible to participate in a clinical trial?
Each clinical trial has eligibility
criteria, which are requirements that patients must
meet before they can participate. Eligibility criteria might
include information about:
- Age and sex
- Type of cancer
- Stage (extent) of the cancer
- Previous treatments that you must, or must not, have
had
- Length of time since you last received treatment
- Results of certain laboratory tests
- Medicines that you are taking
- Other medical conditions
- Previous history of any other cancer
- Other conditions that are specific to each clinical
trial
If you have found a clinical trial you
might qualify for, talk to your doctor, or contact the clinical
trial’s principal investigator or research nurse.
Do cancer patients
ever receive placebos (inactive medicines) in a clinical trial?
Cancer patients in a clinical trial always receive the best
standard treatment available or a new treatment that researchers
believe is as good or better.
A placebo is a substance that
looks like medicine, but is not. Cancer patients are given
placebos in a randomized trial only under unusual circumstances.
If a placebo is used, researchers may give patients in the
control group a placebo in combination with standard
treatment to compare standard treatment alone to
standard treatment with a new drug.
Who sponsors M.
D. Anderson’s clinical trials?
The U.S. National Cancer Institute (NCI) sponsors many of M. D.
Anderson’s clinical trials. Drug companies may also sponsor
clinical trials. This is because these companies must show that
their drugs and medical devices are safe and effective in order
to receive FDA approval and become available to the public. M.
D. Anderson and nonprofit organizations also sometimes sponsor
clinical trials.
How do M. D.
Anderson patients pay for clinical trials?
The clinical trial sponsor (whether it is the
government or a company) may pay for the experimental treatment,
special testing, extra doctor visits, travel time and travel
expenses.
Some health insurance companies also will cover routine
costs in clinical trials. Some health insurance companies will
cover the costs of procedures that patients would have even if
they were not in a clinical trial (routine costs). For Medicare
patients, routine costs are covered in all Medicare-qualified
clinical trials.
You will be responsible for any costs
not covered by the clinical trial sponsor or your health
insurance company. Therefore, be sure to ask questions before
deciding to participate, especially to confirm what costs your
health insurance company will cover.
For financial assistance or questions about insurance
coverage, call M. D. Anderson’s Patient Business Services at
(713) 792-7188.
After the clinical
trial ends, what happens to the information and results?
Researchers give patients a number or code to protect their
identities. When the clinical trial results are published,
patients’ names are not used. The research team may
access clinical trial information to help the study sponsor
submit data to the FDA for approval.
If you want to read what has been
published about a clinical trial that you participated in,
contact your doctor. Ask for the name of the journal, date of
publication, lead author and title of the study.
The Learning
Center staff can help you locate a copy of the article.
How do patients find a
clinical trial at M. D. Anderson?
There are several
ways to learn more about clinical trials conducted at M. D.
Anderson:
Where can I find
additional information?
M. D.
Anderson Information Line: (800) 392-1611, option 3.
Trained health information specialists provide information about
M. D. Anderson’s clinical trials.
National Cancer Institute’s Cancer Information
Service: (800) 4-CANCER or (800) 422-6237. Trained
information specialists can help callers determine whether they
are eligible for various protocols.
The Learning Center: a free consumer health
library with the latest information on cancer care, support,
prevention and general health and wellness issues. Locations
provide a wide range of materials, and each site’s resources are
different. Please call ahead to learn which location contains
the resources you need. The Learning Center staff provides
skilled, individualized service and will be happy to help you.
The Learning Center provides materials for information and
convenience only. They are not to be substituted for medical
advice. Medical information is often controversial and
continually changes. Please consult your health care provider to
discuss your specific concerns. |
|
|
|
Categories to describe. Types of Cancer, Types of Cancer Bladder
Cancer Breast Cancer Colon CancerAlso see Colorectal Cancer Hodgkin's
Disease Kidney Cancer Leukemia Also see ALL, AML, CLL Lung Cancer Also see
Small Cell, Non Small Cell Lymphoma Also see B-Cell Lymphoma Melanoma
Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer
Also see Rectum Cancer Skin Cancer Also see Basal Cell, Squamous Cell
Additional Cancer Types Adrenal Cancer
Bile Duct Cancer Also see Extrahepatic Bile Duct Cancer Bone Cancer Brain
Cancer Cervical Cancer Esophageal Cancer
Gallbladder Cancer Gastric Cancer Head & Neck Cancer Intestinal Cancer
Laryngeal Cancer Liver Cancer Mesothelioma
Multiple Myeloma Oral Cancer Pharyngeal Cancer Stomach Cancer Testicular
Cancer Uterine Cancer Vaginal Cancer
Vulvar Cancer Other Cancer Factors: |
Hi,
I hope the information on this compendium website will be helpful. It
is
collected from around
the internet. I can not guarantee its accuracy. It is quoted
from others. Check your doctor, lawyer or investment advisor before making any
new decisions from my websites. This data will give you something to
help you get started.
If you have additional information on this topic send it to me
by e-mail. Click Here.
I will add it for others to see.
If you have serious feelings or knowledge about ANY
SUBJECT then "MAKE A DIFFERENCE IN THE WORLD" by writing
about it.
" Publish or Perish!"
I will put it one of my
internet
directories. You
will be heard. It is
free! Brian Nelson
713-467-3025.
|
|
Misspelled words used to find this page 3 of 3tlatmiegnt,
tlheatmeignt, treetmeignt, trheaitmant, tletmiegnt, treatmiegnt,
treaitmeignt, tleaitment, tratmant, triatmiegnt, tretmant, tratment,
tliatmiegnt, treetmant, tretment, tleatmant, treetment, triatment, tlatmant,
tleatment, triatmant, tletmant, tlatment, tliatment, tleetmant, tletment,
tliatmant, tleetment, triatmeignt, treatmant, tliatmeignt, treatnemt,
treatmemt, treatmetn, treatmnet, treatemnt, treamtent, tretament, traetment,
teratment, rteatment, treatmen, reatment, pleventiom, prevention,
pleviegnshun, previegntion, pleveignshon, prevanton, plevanchun, prevenchon,
pevention, previegnsion, pleviegntion, preveignshun, plevanton, prevanshon,
plevenchon, prvention, pleviegnsion, previegnchon, pleveignshun,
preveigntion, plevanshon, prevenchun, preention, previegntiom, pleviegnchon,
preveignsion, pleveigntion, prevanshun, plevenchun, prevntion, pleviegntiom,
previegnchun, pleveignsion, preveignchon, plevanshun, prevantion, prevetion,
previegnton, pleviegnchun, preveigntiom, pleveignchon, prevansion,
plevantion, prevenion, pleviegnton, previegnshon, pleveigntiom, preveignchun,
plevansion, prevanchon, preventin, pleviegnshon, preveignton, pleveignchun,
prevantiom, plevanchon, preventiom, previegnshun, pleveignton, preveignshon,
plevantiom, prevanchun, plevension, preventon, prevenshun, prevenshon,
plevention, pleventon, plevenshun, plevenshon, prevension, prevent1on,
prevemtion, preventino, preventoin, preveniton, prevetnion, prevnetion,
preevntion, prveention, pervention, rpevention, preventio, revention,
diagnostic, dyagnoestik, diagnostik, daignoestik, daignostik, dagnostic,
diagnoustic, dyagnostik, dignostic, dyagnoustic, dianostic, daignoustic,
diagostic, diagnoustik, diagnoestic, diagnstic, dyagnoustik, dyagnoestic,
diagnotic, daignoustik, daignoestic, diagnosic, diagnoestik, diagnostc,
daignostic, dyagnostic, d1agnost1c, diagmostic, diagnostci, diagnositc,
diagnotsic, diagnsotic, diagonstic, diangostic, diganostic, idagnostic,
diagnosti, iagnostic, breast, beast, brest, breest, bleast, blest, bleest,
brheaist, briast, bliast, breaist, brheast, bast, best, beest, biast, brast,
blast, brheas, bras, brheais, blas, bres, bles, brees, blees, brias, blias,
breas, breais, bleas, breats, bresat, braest, berast, rbeast, breat, reast,
clincal, clinial, clinicl, clinical, cinical, clnical, cliical, crinical,
clinicar, crinicar, clinca, clinica, clinia, crinica, cleignica, creignica,
cliegnica, criegnica, cinica, clnica, cliica, c11n1ca1, cl1n1cal, climical,
clinicla, cliniacl, clincial, cliincal, clniical, cilnical, lcinical,
linical, trial, trair, tlair, treal, trear, tleal, tlear, tlail, tliar,
trail, triar, tlial, trias, trais, tlias, tlais, tleas, treas, trials,
trairs, tlails, tlials, tlairs, triars, tliars, rials, rails, lials, lails,
riars, liars, trails, treals, trears, tleals, tlears, rairs, lairs, tr1a1s,
tr1als, triasl, trilas, tirals, rtials, trils, trals, tials,patient, patent,
patiet, ptient, paient, patint, patieignt, patiiegnt, pateint, patant,
pateignt, patiegnt, pat1ent, patiemt, patietn, patinet, paitent, ptaient,
aptient, patien, atient"> |
Blue Box
2
Brian Nelson